SCHEMBL2667956

SCHEMBL2667956

CC(C)=C/C=C(/C)CCc1n[nH]c2ccc(C(F)(F)F)cc12

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MAP2K4 P45985 4/20 0.44
▸ MAPK1 P28482 3/20 0.44
▸ MAPK6 Q16659 3/20 0.44
▸ MAPKAPK3 Q16644 2/20 0.44
▸ MAPKAPK2 P49137 1/20 0.44
▸ GSK3B P49841 2/20 0.39
▸ FADS1 O60427 1/20 0.37
▸ KIF11 P52732 4/20 0.35
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ CCR2 P41597 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ TRPA1 O75762 3/20 0.34
▸ MAPKAPK5 Q8IW41 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10271451 0.75 MAP2K4 (0.52) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK2
SCHEMBL7434684 0.75 MAP2K4 (0.50) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK2
SCHEMBL14487354 0.70 MAP2K4 (0.56) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK2
SCHEMBL14487968 0.69 MAP2K4 (0.49) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK2
SCHEMBL27956768 0.68 MAP2K4 (0.51) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK2
SCHEMBL10220250 0.68 MAP2K4 (0.54) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK2
SCHEMBL13122324 0.67 MAP2K4 (0.56) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK2
SCHEMBL2409215 0.65 MAP2K4 (0.58) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK2
SCHEMBL25241733 0.64 MAP2K4 (0.56) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK2
SCHEMBL2662576 0.64 MAP2K4 (0.56) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007075847-A2 GLUCOKINASE ACTIVATORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-07-05 — — WO disclosed
Send feedback